TYRA vs SRPT
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TYRA · TYRA BIOSCIENCES, INC.$20.12 ▲ 1.98%
SRPT · Sarepta Therapeutics$13.33 ▼ 5.93%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TYRA -9.6%
- SRPT -29.5%
Head to head
| Metric | TYRA | SRPT |
|---|---|---|
| Price | $20.12 | $13.33 |
| Change today | ▲ 1.98% | ▼ 5.93% |
| Market cap | $1.39B | $1.43B |
| Return, 3 months | -22.9% | -26.5% |
| Return, year to date | -23.5% | -38.1% |
| Return, 1 year | -4.7% | -24.6% |
| P/E (TTM) | – | – |
| P/B | 2.0 | 0.9 |
| P/E percentile vs own 5y | 67th | 43rd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -4.5% |
| Net profit growth (YoY) | -71.2% | +43.7% |
| Gross margin | – | 56.8% |
| Operating margin | – | -0.4% |
| Net margin | – | -5.9% |
| Return on equity | -34.9% | -8.0% |
| Analyst target vs. price | +137.5% | +67.5% |
| Analyst buy share | 100% | 20% |
| RSI (14) | 45 | 25 |
| 30-day volatility | 47.1% | 59.6% |
| Max drawdown, 1 year | -53.2% | -44.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SRPT is the largest of the group by market value.
- TYRA has returned the most over the past year.
- TYRA has been the calmest stock over the last 30 days.